Singaporean firm Mirxes enters Hong Kong to tap into growing multi-cancer early-stage screening market in Greater Bay Area
Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, expects China’s multi-cancer early-stage screening market to expandThe start-up’s move to Hong Kong followed its application in July for an IPO in the city’s stock exchange
Source: thestar.com.my